Guided Therapeutics (GTHP) Accounts Payables (2010 - 2025)
Guided Therapeutics recorded quarterly Accounts Payables of $2.4 million in Q4 2025, up 1.43% quarter-over-quarter from $2.4 million in Q3 2025, and up 15.38% year-over-year from $2.1 million in Q4 2024.
Guided Therapeutics' Accounts Payables history runs 16 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 15.38% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (up 15.38% YoY), while the FY2025 annual figure was $2.4 million, up 15.38% from the prior year.
- Accounts Payables came in at $2.4 million for Q4 2025 at Guided Therapeutics, up from $2.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.5 million in Q1 2022 to a low of $29000.0 in Q1 2023.
- A 5-year average of $1.9 million and a median of $2.2 million in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables sank 98.83% in 2023 and surged 6534.48% in 2024, its largest moves.
- Guided Therapeutics' Accounts Payables stood at $87000.0 in 2021, then surged by 2412.64% to $2.2 million in 2022, then declined by 8.92% to $2.0 million in 2023, then rose by 5.17% to $2.1 million in 2024, then increased by 15.38% to $2.4 million in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $2.4 million, $2.4 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.57 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.33 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 338.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 75,000.00 |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 87,000.00 |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 2.38 Mn |
| Mar 31, 2021 | 2.43 Mn |
| Dec 31, 2020 | 2.42 Mn |
| Sep 30, 2020 | 116,000.00 |
| Jun 30, 2020 | 2.79 Mn |
| Mar 31, 2020 | 2.84 Mn |
| Dec 31, 2019 | 136,000.00 |
| Sep 30, 2019 | 2.96 Mn |
| Jun 30, 2019 | 99,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | 3.01 Mn |
| Sep 30, 2018 | 2.97 Mn |
| Jun 30, 2018 | 2.96 Mn |
| Mar 31, 2018 | 2.98 Mn |
| Dec 31, 2017 | 3.02 Mn |
| Sep 30, 2017 | 2.97 Mn |
| Jun 30, 2017 | 2.89 Mn |
| Mar 31, 2017 | 2.75 Mn |
| Dec 31, 2016 | 2.60 Mn |
| Sep 30, 2016 | 2.45 Mn |
| Jun 30, 2016 | 2.21 Mn |
| Mar 31, 2016 | 1.98 Mn |
| Dec 31, 2015 | 1.82 Mn |
| Sep 30, 2015 | 1.47 Mn |
| Jun 30, 2015 | 1.96 Mn |
| Mar 31, 2015 | 1.56 Mn |
| Dec 31, 2014 | 1.73 Mn |
| Sep 30, 2014 | 1.66 Mn |
| Jun 30, 2014 | 1.06 Mn |
| Mar 31, 2014 | 1.27 Mn |
| Dec 31, 2013 | 891,000.00 |
| Sep 30, 2013 | 822,000.00 |
| Jun 30, 2013 | 986,000.00 |
| Mar 31, 2013 | 878,000.00 |
| Dec 31, 2012 | 765,000.00 |
| Sep 30, 2012 | 1.04 Mn |
| Jun 30, 2012 | 1.07 Mn |
| Mar 31, 2012 | 863,000.00 |
| Dec 31, 2011 | 1.10 Mn |
| Jun 30, 2011 | 937,000.00 |
| Dec 31, 2010 | 915,000.00 |